CONTENT

This web page had the following in the homepage, "The ATB200-02 study is an international, multi-center, study in adult subjects with Pompe disease." Our analyzers saw that the web page stated " The purpose of this study is to find out if AT2221 can be safely used with ATB200 and will increase ATB200 in the bloodstream." The Website also said " The ATB200-02 Study is open to males and females aged 18-65 with Pompe disease, who are Enzyme Replacement Therapy ERT-experienced subjects ambulatory on a stable ERT dose and regimen, ERT-experienced subjects non-ambulatory or ERT-Naïve subjects ambulatory." The website's header had AT2220-ERT Co-Administration Therapy Study pharmacological chaperone treatment Pompe disease small molecule drugs proteins enzyme replacement therapy alternative amicus therapeutics clinical trial pharmacokinetics alglucosidase alfa as the most important optimized keyword.